DSC1

gene
On this page

Also known as CDHF1

Summary

DSC1 (desmocollin 1, HGNC:3035) is a protein-coding gene on chromosome 18q12.1, encoding Desmocollin-1 (Q08554). A component of desmosome cell-cell junctions which are required for positive regulation of cellular adhesion.

The protein encoded by this gene is a calcium-dependent glycoprotein that is a member of the desmocollin subfamily of the cadherin superfamily. These desmosomal family members, along with the desmogleins, are found primarily in epithelial cells where they constitute the adhesive proteins of the desmosome cell-cell junction and are required for cell adhesion and desmosome formation. A subtype of IgA pemphigus, a life-threatening autoimmune disease, is characterized by the presence of autoantibodies that target the encoded protein. The desmosomal family members are arranged in two clusters on chromosome 18. Alternative splicing of this gene results in multiple transcript variants. At least one of these variants encodes a preproprotein that is proteolytically processed to generate the mature protein.

Source: NCBI Gene 1823 — RefSeq curated summary.

At a glance

  • Clinical variants (ClinVar): 126 total — 2 pathogenic
  • Druggable target: yes — 1 molecules with ChEMBL bioactivity
  • MANE Select transcript: NM_024421

Identifiers

Gene identifiers

FieldValue
HGNC IDHGNC:3035
Approved symbolDSC1
Namedesmocollin 1
Location18q12.1
Locus typegene with protein product
StatusApproved
AliasesCDHF1
Ensembl geneENSG00000134765
Ensembl biotypeprotein_coding
OMIM125643
Entrez1823

Gene structure

Transcript identifiers

Ensembl transcripts: 2 — 2 protein_coding

ENST00000257197, ENST00000257198

RefSeq mRNA: 2 — MANE Select: NM_024421 NM_004948, NM_024421

CCDS: CCDS11894, CCDS11895

Canonical transcript exons

ENST00000257198 — 16 exons

ExonStartEnd
ENSE000005237073114004231140301
ENSE000006675443113159431131842
ENSE000006675483113256831132689
ENSE000006675493113389131134130
ENSE000006675543114199931142184
ENSE000006675553114365731143791
ENSE000006675563114561131145777
ENSE000006675623115944531159529
ENSE000007968893115737131157573
ENSE000007968903115604331156162
ENSE000007968913115477431154929
ENSE000007968923114849831148642
ENSE000007968973113974831139890
ENSE000007968983113457231134784
ENSE000035551523112923631130711
ENSE000039025553116253231162856

Expression profiles

Bgee: expression breadth ubiquitous, 102 present calls, max score 99.63.

FANTOM5 (CAGE): breadth tissue_specific, TPM avg 2.1944 / max 1459.8138, expressed in 80 samples.

FANTOM5 promoters (3 alternative TSS)

Promoter IDTPM avgSamples expressed
1715611.329445
1715630.550749
1715620.314316

Top tissues by expression

258 total, by Bgee expression score (0-100, higher = more expressed):

TissueAnatomy IDExpression scoreQuality
upper leg skinUBERON:000426299.63gold quality
skin of hipUBERON:000155499.51gold quality
upper arm skinUBERON:000426399.38gold quality
penisUBERON:000098999.19gold quality
nippleUBERON:000203098.87gold quality
mammalian vulvaUBERON:000099798.44gold quality
zone of skinUBERON:000001496.70gold quality
skin of legUBERON:000151196.44gold quality
skin of abdomenUBERON:000141696.33gold quality
cardiac muscle of right atriumUBERON:000337994.15gold quality
hair follicleUBERON:000207392.93gold quality
cardiac atriumUBERON:000208181.72gold quality
right atrium auricular regionUBERON:000663180.63gold quality
myocardiumUBERON:000234978.95gold quality
gingival epitheliumUBERON:000194978.10gold quality
gingivaUBERON:000182877.75gold quality
male germ line stem cell (sensu Vertebrata) in testisCL:0000089 ∩ UBERON:000047377.23gold quality
buccal mucosa cellCL:000233675.64gold quality
tongue squamous epitheliumUBERON:000691970.23gold quality
pigmented layer of retinaUBERON:000178267.47gold quality
vena cavaUBERON:000408765.80gold quality
heartUBERON:000094865.70gold quality
heart left ventricleUBERON:000208463.68gold quality
cardiac ventricleUBERON:000208263.45gold quality
oral cavityUBERON:000016763.25silver quality
squamous epitheliumUBERON:000691462.46silver quality
heart right ventricleUBERON:000208058.04gold quality
esophagus squamous epitheliumUBERON:000692057.63gold quality
cervix epitheliumUBERON:000480157.56silver quality
epithelium of esophagusUBERON:000197657.01gold quality

Single-cell (SCXA)

Detected in 1 experiment(s), a significant marker in 1.

ExperimentMarker?Max mean expression
E-ANND-3yes4.88

Regulation

Is transcription factor: no

miRNA regulators (miRDB)

104 targeting DSC1, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):

miRNAMax scoreAvg scoremiRNA target_count
HSA-MIR-518D-5P100.0067.51979
HSA-MIR-518E-5P100.0067.66954
HSA-MIR-518F-5P100.0067.51979
HSA-MIR-519A-5P100.0067.66954
HSA-MIR-519B-5P100.0067.66954
HSA-MIR-519C-5P100.0067.66954
HSA-MIR-520C-5P100.0067.51979
HSA-MIR-522-5P100.0067.66954
HSA-MIR-523-5P100.0067.66954
HSA-MIR-526A-5P100.0067.51979
HSA-MIR-318599.9968.121959
HSA-MIR-23B-5P99.9866.07587
HSA-MIR-7152-3P99.9767.47849
HSA-MIR-568899.9673.234504
HSA-MIR-495-3P99.9672.814197
HSA-MIR-55999.9572.283609
HSA-MIR-548AB99.9571.313488
HSA-MIR-23A-5P99.9465.39468
HSA-MIR-548A-5P99.9471.273482
HSA-MIR-548AR-5P99.9471.283515
HSA-MIR-101-3P99.9475.032230
HSA-MIR-548AD-5P99.9471.233502
HSA-MIR-548AE-5P99.9471.233502
HSA-MIR-548AK99.9471.243488
HSA-MIR-548AM-5P99.9471.243488
HSA-MIR-548AP-5P99.9471.143489
HSA-MIR-548AQ-5P99.9471.343426
HSA-MIR-548AS-5P99.9471.223482
HSA-MIR-548AU-5P99.9471.243488
HSA-MIR-548AY-5P99.9471.233502

Literature-anchored findings (GeneRIF, showing 11)

  • The ultrastructural modifications of desmosomes during terminal differentiation of hair follicles are paralleled by the modulation of the synthesis of desmocollin 1. (PMID:15140019)
  • in majority of patients with Netherton syndrome, Dsg1 & Dsc1 were reduced in living layers of epidermis; SCTE-like & SCCE-like activities were increased, suggesting these proteases participate in premature degradation of corneodesmosomal cadherins (PMID:16628198)
  • Increased Dsc1 protein is associated with colorectal cancer (PMID:17088906)
  • High expression of desmocollin 1 (DSC1) was observed in 41.6%, DSC2 in 58.0%, DSC3 in 61.4%, E-cadherin in 71.4%, CDX2 in 58.0%, PITX1 in 55.0%, CDK4 in 0.2%, TLE1 in 1.3%, Factor H in 42.5%, and MDM2 in 0.2% of colorectal carcinomas. (PMID:22438068)
  • Low expression of DSC 1, 2, and 3 was observed in 55, 54, and 79 % of liver metastases. (PMID:23975055)
  • Increased expression of DSC1 can promote the occurrence of head and neck squamous cell carcinoma (HNSCC) and is associated with tumor. The increased expression of DSC1 also indicates a poor prognosis of the patients with HNSCC. (PMID:27601166)
  • DSC1 expression is significantly downregulated in human masticatory mucosa during wound healing (PMID:28005267)
  • desmocollin-1 (DSC1) is validated as a protein connected with lymph node status of luminal A breast cancer, tumor grade, and Her-2 status and catechol-O-methyltransferase is successfully verified as a protein associated with lymph node metastasis of triple negative breast cancer. (PMID:31617665)
  • CircRAB11FIP1 promoted autophagy flux of ovarian cancer through DSC1 and miR-129. (PMID:33637694)
  • Uniting biobank resources reveals novel genetic pathways modulating susceptibility for atopic dermatitis. (PMID:34454985)
  • Desmocollin-1 is associated with pro-metastatic phenotype of luminal A breast cancer cells and is modulated by parthenolide. (PMID:37620794)

Cross-species orthologs

3 orthologs

OrganismSymbolGene ID
danio_reriodsc2lENSDARG00000039677
mus_musculusDsc1ENSMUSG00000044322
rattus_norvegicusDsc1ENSRNOG00000056258

Paralogs (6): DSG2 (ENSG00000046604), DSC2 (ENSG00000134755), DSG3 (ENSG00000134757), DSG1 (ENSG00000134760), DSC3 (ENSG00000134762), DSG4 (ENSG00000175065)

Protein

Protein identifiers

Desmocollin-1Q08554 (reviewed: Q08554)

Alternative names: Cadherin family member 1, Desmosomal glycoprotein 2/3

All UniProt accessions (2): Q08554, Q9HB00

UniProt curated annotations — full annotation on UniProt →

Function. A component of desmosome cell-cell junctions which are required for positive regulation of cellular adhesion. Required for desmosome adhesion strength between the granular layers of the epidermis, as a result moderates epidermal proliferation and differentiation. Is therefore required to maintain postnatal epidermal barrier function and normal hair follicle morphology into adulthood.

Subunit / interactions. Binds to JUP/plakoglobin.

Subcellular location. Cell membrane. Cell junction. Desmosome.

Tissue specificity. Strongly expressed in epidermis, less in lymph node and tongue.

Domain organisation. Calcium may be bound by the cadherin-like repeats. Three calcium ions are usually bound at the interface of each cadherin domain and rigidify the connections, imparting a strong curvature to the full-length ectodomain.

Isoforms (2)

UniProt IDNamesCanonical?
Q08554-11A, DG2yes
Q08554-21B, DG3

RefSeq proteins (2): NP_004939, NP_077739* (*=MANE)

Domains & families (InterPro)

IDNameType
IPR002126Cadherin-like_domDomain
IPR009122Desmosomal_cadherinFamily
IPR014868Cadherin_pro_domDomain
IPR015919Cadherin-like_sfHomologous_superfamily
IPR020894Cadherin_CSConserved_site
IPR027397Catenin-bd_sfHomologous_superfamily
IPR050971Cadherin-domain_proteinFamily

Pfam: PF00028, PF08758

UniProt features (74 total): strand 41, turn 11, domain 5, sequence variant 3, glycosylation site 2, splice variant 2, helix 2, topological domain 2, signal peptide 1, propeptide 1, modified residue 1, sequence conflict 1, chain 1, transmembrane region 1

Structure

Experimental structures (PDB)

1 structures.

PDBMethodResolution (Å)
5IRYX-RAY DIFFRACTION3.1

Predicted structure (AlphaFold)

ModelpLDDTFraction very-high
AF-Q08554-F177.160.49

Functional residue map

Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.

Post-translational modifications (1): 385

Glycosylation sites (2): 165, 546

Function

Pathways and Gene Ontology

Reactome pathways

3 pathways

IDPathway
R-HSA-6798695Neutrophil degranulation
R-HSA-6805567Keratinization
R-HSA-6809371Formation of the cornified envelope

MSigDB gene sets: 134 (showing top): GSE37336_LY6C_POS_VS_NEG_NAIVE_CD4_TCELL_DN, GOBP_NEGATIVE_REGULATION_OF_EPITHELIAL_CELL_PROLIFERATION, GOBP_MORPHOGENESIS_OF_AN_EPITHELIUM, GOBP_EPITHELIUM_DEVELOPMENT, REACTOME_INNATE_IMMUNE_SYSTEM, GOBP_EPIDERMIS_MORPHOGENESIS, JAEGER_METASTASIS_DN, GOCC_SECRETORY_GRANULE, KAAB_HEART_ATRIUM_VS_VENTRICLE_UP, GOBP_CELLULAR_COMPONENT_MAINTENANCE, CEBPB_01, GOBP_CELL_CELL_ADHESION, GOBP_CELL_JUNCTION_ORGANIZATION, chr18q12, RICKMAN_TUMOR_DIFFERENTIATED_WELL_VS_POORLY_DN

GO Biological Process (7): desmosome maintenance (GO:0002160), homophilic cell-cell adhesion (GO:0007156), hair follicle morphogenesis (GO:0031069), negative regulation of epithelial cell proliferation (GO:0050680), establishment of skin barrier (GO:0061436), cell-cell adhesion (GO:0098609), cell adhesion (GO:0007155)

GO Molecular Function (3): calcium ion binding (GO:0005509), protein binding (GO:0005515), metal ion binding (GO:0046872)

GO Cellular Component (9): cornified envelope (GO:0001533), plasma membrane (GO:0005886), gap junction (GO:0005921), membrane (GO:0016020), desmosome (GO:0030057), extracellular exosome (GO:0070062), ficolin-1-rich granule membrane (GO:0101003), cell junction (GO:0030054), anchoring junction (GO:0070161)

Reactome top-level categories

Rollup of top-3 pathways:

CategoryPathways
Innate Immune System1
Developmental Biology1
Keratinization1

GO top-level categories

Rollup of top GO terms by namespace:

CategoryTerms
cell-cell junction2
cellular anatomical structure2
desmosome organization1
cell-cell junction maintenance1
cell-cell adhesion1
hair follicle development1
anatomical structure morphogenesis1
hair cycle process1
epidermis morphogenesis1
negative regulation of cell population proliferation1
epithelial cell proliferation1
regulation of epithelial cell proliferation1
skin epidermis development1
cell adhesion1
cellular process1
metal ion binding1
binding1
cation binding1
plasma membrane1
membrane1
cell periphery1
extracellular vesicle1
secretory granule membrane1
tertiary granule1
ficolin-1-rich granule1
cell junction1

Protein interactions and networks

STRING

624 interactions, top by confidence (×1000):

Protein AProtein BPartner UniProtScore
DSC1CDSNQ15517995
DSC1DSG1Q02413987
DSC1DSPP15924805
DSC1KLK7P49862647
DSC1PPLO60437638
DSC1JUPP14923636
DSC1ING1Q9UK53613
DSC1DSG3P32926600
DSC1SPINK5Q9NQ38595
DSC1PKP1Q13835586
DSC1LORICRINP23490577
DSC1EVPLQ92817573
DSC1FLG2Q5D862571
DSC1FLGP20930544
DSC1DSTQ03001540

IntAct

60 interactions, top by confidence:

ABTypeScore
PIK3CAPIK3R1psi-mi:“MI:0914”(association)0.960
CFTRESYT2psi-mi:“MI:2364”(proximity)0.710
CFTRESYT2psi-mi:“MI:0914”(association)0.710
NCBP2KPNA3psi-mi:“MI:0914”(association)0.640
MAPK7PFDN6psi-mi:“MI:0914”(association)0.640
DSG1DSC1psi-mi:“MI:0407”(direct interaction)0.620
KSR2POLR3Apsi-mi:“MI:0914”(association)0.530
CFTRCNOT1psi-mi:“MI:0914”(association)0.480
UBASH3BBCR/ABL fusionpsi-mi:“MI:0914”(association)0.460
DSC1DSG2psi-mi:“MI:0407”(direct interaction)0.440
GNAT3psi-mi:“MI:0915”(physical association)0.400
BCAR1MYO1Cpsi-mi:“MI:0914”(association)0.350
DLDNFKBIEpsi-mi:“MI:0914”(association)0.350
DLDEIF3Dpsi-mi:“MI:0914”(association)0.350
METTL3TUBAL3psi-mi:“MI:0914”(association)0.350
METTL14HMGB1P1psi-mi:“MI:0914”(association)0.350
APBB1SSPOPpsi-mi:“MI:0914”(association)0.350
LRRK2psi-mi:“MI:0914”(association)0.350
POC5CEP290psi-mi:“MI:0914”(association)0.350
POC5DSC2psi-mi:“MI:0914”(association)0.350
AP3B1psi-mi:“MI:0914”(association)0.350
SLX4MYO1Cpsi-mi:“MI:0914”(association)0.350
USP1psi-mi:“MI:0914”(association)0.350

BioGRID (147): DSC1 (Affinity Capture-MS), DSC1 (Affinity Capture-MS), DSC1 (Affinity Capture-MS), DSC1 (Affinity Capture-MS), DSC1 (Affinity Capture-MS), DSC1 (Affinity Capture-MS), DSC1 (Affinity Capture-MS), DSC1 (Affinity Capture-MS), DSC1 (Affinity Capture-MS), DSC1 (Affinity Capture-MS), DSC1 (Affinity Capture-MS), DSC1 (Affinity Capture-MS), DSC1 (Affinity Capture-MS), DSC1 (Affinity Capture-MS), DSC1 (Affinity Capture-MS)

ESM2 similar proteins: A0A8M2BIB6, F1QSQ0, F8W3X3, H2EQR6, O35902, O54800, O55111, O93319, P32926, P33545, P55280, P55285, P55286, P55287, P55288, P55289, P55292, P55849, P55850, P70407, P70408, P79995, P97291, P97326, Q01107, Q02413, Q02487, Q08554, Q08DJ5, Q13634, Q14126, Q14574, Q28060, Q3SWX5, Q5DWV1, Q5RJH3, Q61495, Q68SP4, Q6W3B0, Q7TMD7

Diamond homologs: A0A8M2BIB6, B0KW95, B2KI42, B4USZ0, F1PAA9, H2EQR6, O18926, O35902, O55075, O55111, O88277, P08641, P09803, P10287, P10288, P12830, P15116, P19022, P19534, P19535, P20310, P22223, P24503, P30944, P32926, P33145, P33146, P33147, P33148, P33150, P33152, P33545, P39038, P55283, P55290, P55291, P55292, P55849, P55850, P79883

SIGNOR signaling

0 interactions.

Enriched among interaction partners

Reactome pathways and GO biological processes over-represented among this gene’s 79 IntAct physical interaction partners (hypergeometric vs the genome-wide background, BH-FDR, gene-set size 15–500, ranked by fold). A functional readout of the neighbourhood — distinct from this gene’s own memberships above, and biased toward well-studied / hub proteins, so read it as themes rather than proof.

GO biological processes:

GO termPartnersFoldFDR
cell-cell adhesion69.2×5e-03

Disease & clinical

Clinical variants and AI predictions

ClinVar

126 variants total. Per-class counts are floors (≥ shown; pagination cap):

ClassificationCount (floor)
Pathogenic2
Likely pathogenic0
Uncertain significance113
Likely benign1
Benign4

Top pathogenic / likely-pathogenic (2)

Variant IDHGVSClassification
151144GRCh38/hg38 18q12.1(chr18:29365057-31236305)x1Pathogenic
3242756NC_000018.9:g.(?28647981)(29178638_?)delPathogenic

SpliceAI

2153 predictions. Top by Δscore:

VariantEffectΔscore
18:31130712:C:CCacceptor_gain1.0000
18:31131592:A:ACdonor_gain1.0000
18:31131593:C:CCdonor_gain1.0000
18:31131667:C:CAdonor_gain1.0000
18:31132566:A:ACdonor_gain1.0000
18:31132566:A:ATdonor_loss1.0000
18:31132567:C:CCdonor_gain1.0000
18:31132575:T:TAdonor_gain1.0000
18:31132686:ATAC:Aacceptor_gain1.0000
18:31132687:TAC:Tacceptor_gain1.0000
18:31132687:TACC:Tacceptor_loss1.0000
18:31132690:C:CCacceptor_gain1.0000
18:31132690:CTAAA:Cacceptor_loss1.0000
18:31132691:T:Cacceptor_loss1.0000
18:31134568:ATACC:Adonor_loss1.0000
18:31134570:A:ACdonor_gain1.0000
18:31134570:AC:Adonor_gain1.0000
18:31134570:ACC:Adonor_loss1.0000
18:31134570:ACCAT:Adonor_gain1.0000
18:31134571:C:Adonor_loss1.0000
18:31134571:C:CTdonor_gain1.0000
18:31134571:CC:Cdonor_gain1.0000
18:31134571:CCAT:Cdonor_gain1.0000
18:31134571:CCATC:Cdonor_gain1.0000
18:31134574:T:TAdonor_gain1.0000
18:31134781:CCAA:Cacceptor_gain1.0000
18:31134782:CAA:Cacceptor_gain1.0000
18:31134782:CAAC:Cacceptor_gain1.0000
18:31134785:C:CCacceptor_gain1.0000
18:31140045:AAG:Adonor_gain1.0000

AlphaMissense

5893 scored. Top likely-pathogenic:

VariantProtein changeam_pathogenicity
18:31145669:A:GF294S0.999
18:31148562:A:CN236K0.999
18:31148562:A:TN236K0.999
18:31134591:C:AW619C0.998
18:31134591:C:GW619C0.998
18:31140183:A:TV460D0.998
18:31140189:A:TV458D0.998
18:31143757:C:GR325P0.998
18:31148551:G:TP240Q0.998
18:31148560:T:GD237A0.998
18:31148570:C:GD234H0.998
18:31134058:T:GD650A0.997
18:31134593:A:GW619R0.997
18:31134593:A:TW619R0.997
18:31143687:A:CN348K0.997
18:31143687:A:TN348K0.997
18:31143706:A:TI342N0.997
18:31143754:T:GD326A0.997
18:31143755:C:GD326H0.997
18:31143772:A:GL320S0.997
18:31145642:A:TI303N0.997
18:31145709:A:CY281D0.997
18:31145741:T:GD270A0.997
18:31145753:G:TA266D0.997
18:31148560:T:AD237V0.997
18:31148561:C:GD237H0.997
18:31148563:T:AN236I0.997
18:31148568:A:CD234E0.997
18:31148568:A:TD234E0.997
18:31148569:T:AD234V0.997

dbSNP variants (sampled 300 via entrez): RS1000115610 (18:31137496 C>T), RS1000116086 (18:31163258 T>A,C), RS1000462154 (18:31148341 C>T), RS1000609063 (18:31141067 G>A), RS1000711346 (18:31161966 T>C), RS1000864896 (18:31152613 G>A,T), RS1001139724 (18:31149637 T>C), RS1001147937 (18:31158050 C>T), RS1001200864 (18:31147153 A>T), RS1001318004 (18:31158249 A>G), RS1001385196 (18:31159017 C>T), RS1001441228 (18:31130977 T>C), RS1001487799 (18:31149335 A>G), RS1001515879 (18:31153109 T>C), RS1001747353 (18:31143012 T>C)

Disease associations

OMIM: gene MIM:125643 | disease phenotypes: MIM:610476, MIM:105210

GenCC curated gene-disease

Mondo (2): arrhythmogenic right ventricular dysplasia 11 (MONDO:0012506), amyloidosis, hereditary systemic 1 (MONDO:0971004)

Orphanet (2): ATTRV30M amyloidosis (Orphanet:85447), ATTRV122I amyloidosis (Orphanet:85451)

HPO phenotypes

0 total (0 of 0 shown, HPO-id order):

GWAS associations

0 associations (top):

MeSH disease descriptors (1)

DescriptorNameTree numbers
C566471Arrhythmogenic Right Ventricular Dysplasia, Familial, 11 (supp.)

Drugs & pharmacology

Drug and pharmacology data

Is drug target: yes

ChEMBL targets (1): CHEMBL5724910 (SINGLE PROTEIN)

Molecules with ChEMBL bioactivity

1 molecules (phase ≥1), by development phase (incl. off-target/promiscuous compounds). Patent mentions across the top 20 by phase: 1,538 (via chembl_molecule»patent_compound — counts attach to the compound, not the gene–compound relationship, so off-target/promiscuous molecules can dominate).

MoleculeNamePhasePatents
CHEMBL1232461MOLIBRESIB21,538

PharmGKB: 1 entry (VIP=true, CPIC=false)

ChEMBL bioactivities

1 potent at pChembl≥5 of 1 total, top 1 by pChembl (potency: 10 = 0.1 nM, 6 = 1 µM).

pChemblTypeValueUnitMolecule
5.37IC504310nMMOLIBRESIB

PubChem BioAssay actives

1 with measured affinity, of 6 total; 1 most potent distinct compounds. Largely complementary to BindingDB; screening values are coarse (µM, 4 dp), so sub-nM hits tie at the floor.

CompoundAssayTypeValueUnit
2-[(4S)-6-(4-chlorophenyl)-8-methoxy-1-methyl-4H-[1,2,4]triazolo[4,3-a][1,4]benzodiazepin-4-yl]-N-ethylacetamide2179016: Inhibition of DSC1 (unknown origin) incubated for 1 hr by colloidal coomassie staining based LC-MS/MS analysisic504.3100uM

CTD chemical–gene interactions

39 total (human), top 30 by PubMed support.

ChemicalActions (top 5)PubMed papers
Tobacco Smoke Pollutiondecreases expression3
sodium arsenitedecreases expression, increases abundance, decreases reaction2
Antimony Potassium Tartratedecreases expression, increases abundance, decreases reaction2
4-oxoretinoic aciddecreases expression1
triphenyl phosphateaffects expression1
deoxynivalenolincreases expression1
sodium arsenatedecreases expression, increases abundance1
ethyl-p-hydroxybenzoateincreases expression1
terbufosincreases methylation1
arsenitedecreases expression, increases abundance, decreases reaction1
perfluorooctanoic aciddecreases expression1
avobenzonedecreases expression1
antimonitedecreases expression, increases abundance, decreases reaction1
perfluoro-n-nonanoic aciddecreases expression1
U 0126decreases expression, decreases reaction, increases abundance, increases reaction1
rofecoxibaffects expression1
perfluorohexanesulfonic aciddecreases expression1
2-tert-butyl-9-fluoro-3,6-dihydro-7H-benz(h)imidazo(4,5-f)isoquinoline-7-onedecreases expression, decreases reaction, increases reaction1
Alitretinoindecreases expression1
Acetaminophendecreases expression1
Aerosolsdecreases expression1
Arsenicincreases abundance, decreases expression1
Atrazineincreases expression1
Benzo(a)pyreneincreases methylation1
Cadmiumincreases abundance, decreases expression1
Calcitrioldecreases expression, affects cotreatment1
Fonofosincreases methylation1
Estradioldecreases expression1
Ibuprofenaffects expression1
Parathionincreases methylation1

ChEMBL screening assays

6 unique, capped per target: 6 binding

Representative assays (with source publication via chembl_document):

Assay IDTypeDescriptionSource paper
CHEMBL5697746BindingInhibition of DSC1 (unknown origin) assessed as fold change at 10 uM incubated for 1 hr by colloidal coomassie staining based LC-MS/MS analysisInhibition of BET recruitment to chromatin as an effective treatment for MLL-fusion leukaemia. — Nature

Clinical trials (associated diseases)

0 trials via MONDO — disease-level, not drug-specific.